filmov
tv
CBER Advanced Technologies Team
0:07:34
What is CATT? CBER Advanced Technologies Team
1:05:05
FDA | NIH: Regulatory Do’s and Don’ts: Tips from FDA – CBER Segment
7:12:11
Advancing the Utilization and Supporting the Implementation of Innovative Manufacturing Approaches
5:11:55
Advancing the Utilization and Supporting the Implementation of Innovative Manufacturing Approaches
0:57:39
Study Data Standards Update for CBER: Your Guide to a Successful Submission
0:59:34
FDA Lecture: Advancing the Science of Patient Input in the Regulatory Settings
1:10:39
Featured Fireside Chat: FDA Perspective
2:16:18
Pharmaceutical Quality Symposium 2023: Quality, Supply Chain & Advanced Manufacturing – D1 – Part 4
1:24:04
Regulatory Best Practices for Global Access to Medicines Including Anti-TB Medicines Day 1-Session 2
0:51:21
OHDSI Work With The FDA Best Around Vaccine Surveillance (March 23 OHDSI Community Call)
0:54:27
FDA's Sentinel Initiative - Pharmacovigilance 2020
2:14:26
Pharmaceutical Quality Symposium 2023: Quality, Supply Chain & Advanced Manufacturing – D2 – Part 3
1:15:00
Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 3
0:57:09
Overview of CDER’s Real-World Evidence Demonstration Projects
0:48:41
Computer Software Assurance (CSA): Understanding the FDA’s New Draft Guidance
0:15:26
Presenter - Joseph A Huber
0:57:16
eCTD Submission Tools and Software. Peivand Pirouzi, Ph.D.
0:59:10
2019 CCTS FDA Conference - View from Ground Zero: Lessons in Developing Biologic Therapeutics
0:19:32
Peter Marks: The Regulatory Landscape for Genome Editing
0:04:14
How Entrepreneurship Can Be a Force for Good | NYU Shanghai CBER
1:00:11
Human Factors Engineering in Medical Products Reviews (2of14) REdI 2018
1:12:07
Edited Version - Webinar about US Investigational New Drug (IND) Applications.
1:01:47
Wound Care Innovation: The call to clinical action
1:19:19
Generic Drugs Forum (GDF) 2024: Regulatory Considerations to Enhance Generic Drug Access-Day 2, Pt 3
Вперёд